Mvasi

Indicated For

metastatic colorectal cancer, epithelial ovarian cancer, fallopian tube cancer, primary peritoneal cancer, cervical cancer

About This Medication

# Amgen SupportPlus Patient Guide: How to Get Mvasi (bevacizumab-awwb) at Low or No Cost Mvasi (bevacizumab-awwb) is a biosimilar to Avastin used to treat certain cancers, and **Amgen SupportPlus** offers copay assistance to help eligible commercially insured patients reduce out-of-pocket costs.[1][6][7] This guide explains eligibility, application steps, and support options in simple terms to help you access Mvasi affordably. ## About Mvasi (bevacizumab-awwb) Mvasi is an injectable medication that works as a vascular endothelial growth factor (VEGF) inhibitor, helping to slow tumor growth by blocking blood vessel formation in cancers.[7] It's FDA-approved for several uses, including: - First-line treatment of metastatic non-squamous non-small cell lung cancer (NSCLC) in combination with carboplatin and paclitaxel.[7] - First-line treatment of unresectable, locally advanced, recurrent, or metastatic cervical cancer with paclitaxel and cisplatin, or paclitaxel and topotecan.[7] - Treatment of epithelial ovarian, fallopian tube, or primary peritoneal cancer (OC) in various combinations, such as with carboplatin and paclitaxel for advanced stages following surgery, or for platinum-resistant recurrent cases.[7][8] **Important:** Mvasi is always given with chemotherapy and by intravenous infusion: first over 90 minutes, then 60 minutes if tolerated, and 30 minutes for later doses.[7] It's not a cure but helps manage cancer progression. Common side effects include high blood pressure, fatigue, and bleeding risks—discuss with your doctor. Report serious issues to FDA at 1-800-FDA-1088 or Amgen at 1-800-772-6436.[4][7] Always consult your healthcare provider for personalized advice; this guide focuses on financial support, not medical guidance.[1] ## Who Qualifies for Amgen SupportPlus? Amgen SupportPlus provides **copay assistance** primarily for **commercially insured patients** (private or commercial insurance, not government programs like Medicare/Medicaid).[1][6] It's designed to lower out-of-pocket costs like deductibles, copays, or coinsurance for Mvasi prescriptions.[6] - **Key eligibility:** You must have a valid prescription for Mvasi, be 18+, live in the US, and meet program criteria (e.g., not incarcerated).[1][3] - **Income limits:** No strict Federal Poverty Level (FPL) thresholds listed; eligibility focuses on commercial insurance status rather than income. However, program maximums and other criteria apply—call to confirm.[1] - **Exclusions:** Typically not for uninsured, underinsured, or government-insured patients, though separate nonprofit resources may be available.[4][8] ## Income Eligibility Breakdown Amgen SupportPlus copay program does not publish fixed income thresholds like traditional patient assistance programs. Instead, it's tailored for commercially insured patients with high out-of-pocket costs.[6] Here's a summary: | Household Size | Income Threshold | FPL % | Notes | |---------------|------------------|-------|-------| | Individual | Not specified | N/A | Primarily for commercial insurance; call for details[1] | | Couple | Not specified | N/A | Eligibility criteria and maximums apply[6] | | Family of 3 | Not specified | N/A | Focus on copay reduction, not free drug[1] | | Family of 4 | Not specified | N/A | Verify via phone or portal[4] | **Pro tip:** Even without income caps, savings can be significant (up to program limits). Check full terms at enrollment.[6] ## Insurance Requirements - **Must have:** Private/commercial insurance covering Mvasi.[6][8] - **Not eligible:** Medicare, Medicaid, or other federal programs—seek nonprofit aid instead.[4] - Benefits verification and prior authorization help available via Amgen SupportPlus.[4] ## Step-by-Step Application Process Applying is straightforward with **multiple methods**.[1][6] 1. **Gather info:** Prescription for Mvasi, insurance details, personal info (name, address, DOB, phone, email).[3][6] 2. **Enroll online:** Visit https://www.amgensupportplus.com/copay, create an account, and activate a copay card.[6] 3. **Or call:** Dial (866) 264-2778 (Mon-Fri, 9 AM-8 PM ET) for phone enrollment and support.[1][4] 4. **HCP involvement:** Your doctor may need to complete an enrollment form or use the myAmgenPortal.com for benefits verification.[3][4] 5. **Consent:** Agree to data sharing for program services (e.g., copay processing).[3] 6. **Receive copay card:** Use at pharmacy or infusion center to reduce costs instantly.[6] Fax forms to 866-218-4777 if needed.[3] ## Timeline and Delivery - **Processing:** Often instant for copay cards upon enrollment; call for benefits check.[4][6] - **Delivery:** Copay assistance applies at point-of-service (pharmacy/infusion); no home delivery specified. Mvasi is administered in a clinical setting.[7] - **Support hours:** Phone help Mon-Fri 9 AM-8 PM ET.[4] Expect quick activation, but prior authorizations may take longer—Amgen assists.[2][4] ## Alternatives if Denied or Ineligible - **Biosimilars/Reference:** Avastin (reference product) may have similar support.[7] - **Nonprofits:** Independent programs for uninsured/underinsured (Amgen provides info, no control).[4][8] - **Other options:** State programs, manufacturer bridges, or general copay cards. Call (866) 264-2778 for referrals.[1] - **Appeal:** Contact SupportPlus to review denial reasons.[1] ## Additional Support - **Nurse Partners:** Enroll for non-medical support (education, not treatment).[4] - **Resources:** Download guides for billing/coding at amgensupportplus.com.[7] ## Disclaimer This guide is for informational purposes only and based on publicly available data as of 2023-2024.[1][6] Program details can change—verify with Amgen SupportPlus at (866) 264-2778 or https://www.amgensupportplus.com/copay. Not medical/financial advice. Eligibility, terms, and maximums apply; see full conditions online.[6] Consult your doctor for health decisions. Amgen does not guarantee coverage or assistance.[4] (Word count: 1028)

Program information last verified: March 30, 2026